When is calcitonin-salmon (Fortical, Miacalcin) indicated in the treatment of osteoporosis?

Updated: Aug 27, 2020
  • Author: Monique Bethel, MD; Chief Editor: Herbert S Diamond, MD  more...
  • Print

Calcitonin is no longer widely used for treatment of osteoporosis. [126] Nevertheless, it remains an option for patients who are not candidates for other available osteoporosis treatments. Common side effects of nasally administered calcitonin include nasal discomfort, rhinitis, irritation of nasal mucosa, and occasional epistaxis. Nausea, local inflammatory reactions at the injection site, sweating, and flushing are side effects noted with parenteral use.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!